Nath Bio-Genes (India) Ltd

NSE : NATHBIOGENESINDIA24 Jan 2025

FMCG

₹

-3.17 (-1.80%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Ltd

FMCG

NSE : NATHBIOGENESINDIA24 Jan 2025

₹

-3.17 (-1.80%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
08-May-2024	D	In continuance to our intimation dated April 30th 2024, after due deliberation the Board of Directors has recommended dividend for financial year 2023-24 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company. Record date for AGM and Dividend is Friday 09th August 2024 (As Per BSE Announcement dated on 23.07.2024)	09-Aug-2024
22-Apr-2023	D	The outcome of the Board Meeting held on 22nd April 2023. In continuance to our intimations dated April 15th 2023, after due deliberation the Board of Directors has recommended dividend for financial year 2022-23 of Rs. 2/-(i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company Book Closure and record date for upcoming AGM The registrar of members and share transfer book of the Company will be closed from 25th June 2023 to 30th June 2023 for the purpose of holding Annual General Meeting and Declaration of Dividend. Kindly note that the record date is 23rd June 2023 for the purpose of AGM and Dividend. (As per BSE Announcement Dated on 25/04/2023) Intimation for Change in Book Closure and Record Date (As Per BSE Announcement dated on 23.05.2023)	04-Jul-2023
30-May-2022	D	Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2022, inter alia, has recommended dividend for financial year 2021-22 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.	23-Jun-2022
24-Jun-2021	D	Nath Bio-Genes (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2021, inter alia, has recommended dividend for financial year 2020-21 of Rs. 2/- (i.e. 20%) per equity shares of the nominal value of Rs. 10.00 per share fully paid up, subject to approval of shareholders in upcoming Annual General Meeting of the Company.	18-Aug-2021
15-Jan-2025	BC	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve unaudited financial results for the	23-Jan-2025
17-Oct-2024	BC	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve unaudited financial results for the	23-Oct-2024
23-Oct-2024	BC	Outcome of Board Meeting	23-Oct-2024
08-May-2024	BC	Annual General Meeting of the Company to be held on Saturday 17th August 2024 at 11.00 am through video conference/other audio visual means accordance with the applicable circulars issued by the Mini	17-Aug-2024
23-Jul-2024	BC	Record date for AGM and Dividend is Friday 09th August 2024 The registrar of Members and share transfer books of the Company will be closed from 13th August 2024 to 17th August 2024 for the purpo	13-Aug-2024

No Rights has been declared by NATHBIOGENESINDIA

Book Closure

Record Date	Split Date	Purpose
23-Jan-2025	-	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve unaudited financial results for the
23-Oct-2024	-	Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve unaudited financial results for the
23-Oct-2024	-	Outcome of Board Meeting
17-Aug-2024	-	Annual General Meeting of the Company to be held on Saturday 17th August 2024 at 11.00 am through video conference/other audio visual means accordance with the applicable circulars issued by the Mini
13-Aug-2024	01 Jan'1900	Record date for AGM and Dividend is Friday 09th August 2024 The registrar of Members and share transfer books of the Company will be closed from 13th August 2024 to 17th August 2024 for the purpo

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Nath Bio-Genes (India) Ltd ₹173.19(-3.17/-1.80%)	173.19	-3.17	329.13	-20.19	7.94	0.51
Vadilal Industries Ltd ₹3,551.45(-50.65/-1.41%)	3,551.45	-50.65	2,553.49	20.76	24.37	6.48
Agro Tech Foods Ltd ₹874.55(-12.55/-1.41%)	874.55	-12.55	2,131.21	6.02	0.00	4.32
Dabur India Ltd ₹521.65(-2.95/-0.56%)	521.65	-2.95	92,452.81	-2.79	63.96	12.80
Hindustan Unilever Ltd ₹2,368.10(+46.40/2.00%)	2,368.10	+46.40	556,406.71	-3.01	54.39	11.03
Hatsun Agro Product Ltd ₹940.80(+17.20/1.86%)	940.80	+17.20	20,956.16	-14.95	72.82	12.84

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	37.98	4.17	29.22	21.98	21.38
Net Cash from Operating Activities	74.72	38.37	17.05	1.11	9.48
Net Cash Used In Investing Activities	-27.40	-2.88	-19.87	-10.28	-14.44
Net Cash Used In Financing Activities	-9.81	-1.67	-22.23	16.40	5.56
Net Inc./Dec In Cash And Cash Equivalents	37.52	33.82	-25.05	7.23	0.61
Cash And Cash Equivalents At End Of The Year	75.50	37.98	4.17	29.22	21.98

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

45.60%

FII Shareholding

0.19%

DII Shareholding

4.37%

Public Shareholding

49.84%

**Promoter pledged shareholding 45.60%

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Ltd is in the FMCG sector, having a market capitalization of Rs. 331.14 crores. It has reported a sales of Rs. 36.87 crores and a net profit of Rs. 2.66 crores for the quarter ended December 2018. The company management includes , Satish Kagliwal,Dhiraj Rathi,Jeevanlata Kagliwal,Ashu Jain,Vadla Nagbhushanam,Madhukar Deshpande,HITESH RAJNIKANT PUROHIT,Akash Nandkishor Kagliwal (Nath Bio-Genes (India) Ltd) among others.

Chairman

Registered office

Nath House Nath Road,P B No 318,Aurangabad.,Maharashtra,431005

FAX :91-240-2376188

Background

Incorporation Year1993

Face Value₹10

Market Lot1